Buchumschlag

Management of Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell and in Solid Organ Transplantation: Updated Recommendations by the GITMO, SITO, SIMIT, and AMCLI Italian Societies

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Corrado Girmenia, Tiziana Lazzarotto, Massimo Martino, Francesca Bonifazi, Fausto Baldanti, Pierangelo Clerici, Franco Citterio, Luciano De Carlis, Giovanni Barosi, Paolo Antonio Grossi
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Clinical Transplantation
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Resistant/Refractory Cytomegalovirus Retinitis in Solid Organ and Hematopoietic Stem Cell Transplant Recipients: The Cause‐or‐Consequence Dilemma
von: Renato Pascale, et al.
Veröffentlicht: (2026)

Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study
von: Estela Giménez, et al.
Veröffentlicht: (2025)

Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era
von: Hiroki Hosoi, et al.
Veröffentlicht: (2025)

Cytomegalovirus Infection After CD‐34 Selected Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
von: Brennan Collis, et al.
Veröffentlicht: (2025)

Molecular Profile and Dynamics of Commensal Viruses in Brazilian Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
von: Gabriel Montenegro de Campos, et al.
Veröffentlicht: (2025)

Varicella‐Zoster Virus Reactivation After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation, Single‐Center Experience of Acyclovir Prophylaxis
von: Galip Arıcı, et al.
Veröffentlicht: (2024)

Clinical and Economic Impact of CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation: Perspectives from a Middle‐Income Nation
von: Gin Gin Gan, et al.
Veröffentlicht: (2024)

Cidofovir Treatment for Prevention of BK Virus‐Associated Hemorrhagic Cystitis in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
von: Bo Lv, et al.
Veröffentlicht: (2025)

Association of CYP2C19 Single Nucleotide Polymorphism With Hemorrhagic Cystitis After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
von: Weiliang Zhang, et al.
Veröffentlicht: (2026)

Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia With Active Left Neck Tuberculosis: A Case Report
von: Ying He, et al.
Veröffentlicht: (2025)

Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
von: Suneri J. Amin, et al.
Veröffentlicht: (2025)

Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy
von: Hildegard T. Greinix, et al.
Veröffentlicht: (2025)

The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified‐Release Posaconazole Prophylaxis
von: Shio Yen Tio, et al.
Veröffentlicht: (2025)

Clinical and Microbiological Insights Into Invasive Fusariosis Following Allogeneic Hematopoietic Stem Cell Transplantation: A 15‐Year Single‐Center Analysis
von: Jotaro Yamamoto, et al.
Veröffentlicht: (2026)

Utility and Safety of Romiplostim in Pediatric Allogeneic Stem Cell Transplantation
von: Srividhya Senthil, et al.
Veröffentlicht: (2025)

Effects of HPgV‐1 Infections on Clinical Outcomes in Patients With Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Matched Case‐Control Study
von: Zhanjia Li, et al.
Veröffentlicht: (2026)

The Impact of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Cyclosporine Concentration in Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation
von: Zahra Salehi, et al.
Veröffentlicht: (2025)

Effect of Antibiotics With Anaerobic Coverage on Graft‐Versus‐Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta‐Analysis
von: Hiroshi Ito, et al.
Veröffentlicht: (2025)

Transplantation Related Mortality Did Not Show Significant Differences in Patients Aged Above 55 Years With Hematological Malignancies Receiving Allogeneic Hematopoietic Stem Cell Transplantation in a Real‐World Study
von: Jing Liu, et al.
Veröffentlicht: (2025)

HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions
von: Alessandra Mularoni, et al.
Veröffentlicht: (2026)

Lung Biopsies in Patients Referred for Allogeneic Hematopoietic Cell Transplantation: Diagnostic Accuracy, Diagnostic Yield, and Clinical Utility
von: Sergio Rodriguez‐Rodriguez, et al.
Veröffentlicht: (2026)

Aspergillus versicolor Meningitis in a Patient With Refractory Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation
von: Naonori Harada, et al.
Veröffentlicht: (2025)

Twice‐Weekly Micafungin as Antifungal Prophylaxis in Children Undergoing Hematopoietic Stem Cell Transplantation
von: Syaza Ab Rahman, et al.
Veröffentlicht: (2026)

Long‐Term Endocrine Effects of Hematopoietic Stem Cell Transplantation in Children: A Reappraisal
von: Dilek Gürlek Gökçebay, et al.
Veröffentlicht: (2026)

Long‐Term Outcomes of Hematopoietic Stem Cell Transplantation in Mucopolysaccharidoses Patients Without Radiation
von: Mohammad Jahanpanah, et al.
Veröffentlicht: (2025)

Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients
von: Marilyne Daher, et al.
Veröffentlicht: (2025)

Persisting Gaps in Cytomegalovirus Prevention and Management After Solid Organ Transplantation in a Resource‐Limited Setting
von: Guilherme Santoro‐Lopes, et al.
Veröffentlicht: (2025)

Invasive Fungal Disease in Allogeneic Hematopoietic Cell Transplantation: New Risk Factors and New Therapeutic Options in a Changing World
von: Abby P. Douglas, et al.
Veröffentlicht: (2026)

Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance
von: Margaret R. Jorgenson, et al.
Veröffentlicht: (2024)

Acute Appendicitis in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Single‐Center Experience
von: Mustafa Okumuş, et al.
Veröffentlicht: (2026)

Preventing Cat‐Astrophe: Toxoplasma Seroprevalence and Prophylaxis Adherence After Allogeneic Stem Cell Transplant
von: Manogna Metlapalli, et al.
Veröffentlicht: (2026)

The First Phylogenetically Confirmed Hemorrhagic Cystitis Outbreak Among Pediatric Hematopoietic Stem Cell Transplant Recipients
von: Tugba Nukte Tezel, et al.
Veröffentlicht: (2025)

Impact of Early Cyclosporine on Cytokine Release Syndrome and Outcomes in Pediatric Haploidentical Hematopoietic Stem Cell Transplantation
von: Veerendra C. Patil, et al.
Veröffentlicht: (2025)

The Eastern Cooperative Oncology Group Score Rather Than Donor Type Impacts Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients Aged 51–60 Years: A Retrospective Study From the Chinese Blood and Marrow Transplant Registry
von: Xin Zhao, et al.
Veröffentlicht: (2025)

Severe Food Protein‐Induced Enterocolitis Syndrome After Hematopoietic Stem Cell Transplantation: Pediatric Case Report
von: Laura Alonso García, et al.
Veröffentlicht: (2024)

Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
von: Abdallah Mughrabi, et al.
Veröffentlicht: (2026)

Clinically Significant EBV Infection in Allogeneic Stem Cell Transplanted Children Receiving Letermovir as Primary CMV Prophylaxis
von: Christina Oikonomopoulou, et al.
Veröffentlicht: (2025)

Donors Infectious Risk Stratification: Activity of the Italian National Transplant Center
von: Elena Graziano, et al.
Veröffentlicht: (2025)

The Pretransplant EASIX Score Predicts Transplant‐Related Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation for Non‐Malignant Disorders
von: Vedat Uygun, et al.
Veröffentlicht: (2026)

Case Report: Hematopoietic Stem Cell Transplantation to Treat Severe Acquired Aplastic Anemia in a Pediatric Kidney Transplant Recipient
von: Gintarė Mierkienė, et al.
Veröffentlicht: (2025)